View Older Stories View More Recent Stories

Jul 17, 2025 06:48AM H.C. Wainwright Reiterates Sell Rating on Sarepta Therapeutics (SRPT)
Jul 17, 2025 06:42AM Mizuho Reiterates Outperform Rating on Sarepta Therapeutics (SRPT)
Jul 16, 2025 04:57PM ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Sarepta Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SRPT
Jul 16, 2025 04:54PM After-hours movers: United Airlines, Sarepta Therapeutic, MP Materials
Jul 16, 2025 04:01PM Sarepta cuts 36% of workforce, expects $400M in annual savings
Jul 15, 2025 04:51PM ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Sarepta Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SRPT
Jul 15, 2025 10:45AM SRPT INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
Jul 14, 2025 12:39PM SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sarepta Therapeutics
Jul 13, 2025 09:31AM ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Sarepta Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SRPT
Jul 13, 2025 07:48AM Faruqi & Faruqi Notifies Sarepta Therapeutics Investors of a Class Action Lawsuit and Upcoming Deadline - SRPT
Jul 11, 2025 08:42PM ROSEN, A LEADING LAW FIRM, Encourages Sarepta Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SRPT
Jul 11, 2025 04:00PM SRPT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jul 10, 2025 08:37PM ROSEN, LEADING TRIAL ATTORNEYS, Encourages Sarepta Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SRPT
Jul 10, 2025 06:47AM Sarepta Therapeutics (SRPT) PT Lowered to $28 at JPMorgan
Jul 9, 2025 06:07PM ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Sarepta Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SRPT
Jul 9, 2025 02:45PM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sarepta Therapeutics
Jul 9, 2025 01:30PM SRPT INVESTOR ALERT: Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jul 8, 2025 06:02PM ROSEN, A LONGSTANDING LAW FIRM, Encourages Sarepta Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SRPT
Jul 7, 2025 09:20PM SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sarepta Therapeutics
Jul 6, 2025 04:00PM SRPT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jul 6, 2025 10:17AM ROSEN, A LONGSTANDING LAW FIRM, Encourages Sarepta Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SRPT
Jul 5, 2025 10:37AM ROSEN, A LEADING LAW FIRM, Encourages Sarepta Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SRPT
Jul 5, 2025 08:25AM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sarepta Therapeutics
Jul 4, 2025 04:55AM SRPT INVESTOR DEADLINE: Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jul 3, 2025 11:54AM ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Sarepta Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SRPT
Jul 2, 2025 04:34PM Mizuho Reiterates Outperform Rating on Sarepta Therapeutics (SRPT) Following Expert Call
Jul 1, 2025 01:21PM TOP RANKED ROSEN LAW FIRM Encourages Sarepta Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SRPT
Jul 1, 2025 12:45PM SRPT Investors Have the Opportunity to Lead the Sarepta Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
Jun 30, 2025 04:00PM SRPT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jun 30, 2025 12:40PM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sarepta Therapeutics
Jun 30, 2025 12:32PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages Sarepta Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SRPT
Jun 29, 2025 12:18PM ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Sarepta Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SRPT
Jun 29, 2025 07:43AM SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sarepta Therapeutics
Jun 28, 2025 10:30PM SRPT INVESTOR ALERT: Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jun 27, 2025 10:01AM SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sarepta Therapeutics
Jun 25, 2025 03:36PM SRPT SECURITIES ALERT: Sarepta Therapeutics, Inc. Investors are Notified to Contact BFA Law about its Pending Securities Fraud Investigation
Jun 25, 2025 06:41AM H.C. Wainwright Reiterates Sell Rating on Sarepta Therapeutics (SRPT)
Jun 24, 2025 04:43PM FDA investigating deaths due to acute liver failure in non-ambulatory Duchenne muscular dystrophy patients following elevidys
Jun 24, 2025 03:22PM Sarepta Therapeutics, Inc. Investors are Notified to Contact BFA Law to Potentially Recover Losses in Securities Fraud Investigation
Jun 23, 2025 03:18PM SAREPTA FRAUD: BFA Law Reminds Sarepta Therapeutics, Inc. (SRPT) Investors with Losses to Contact the Firm about the Securities Fraud Investigation
Jun 23, 2025 09:03AM Piper Sandler Reiterates Neutral Rating on Sarepta Therapeutics (SRPT)
Jun 21, 2025 08:18AM SRPT FRAUD NOTICE: Sarepta Therapeutics, Inc. Shareholders that Lost Money are Reminded to Contact BFA Law about the Securities Fraud Investigation
Jun 20, 2025 10:18AM Sarepta Therapeutics (SRPT) PT Lowered to $45 at Oppenheimer
Jun 20, 2025 05:35AM William Blair Downgrades Sarepta Therapeutics (SRPT) to Market Perform
Jun 19, 2025 03:46PM SRPT INQUIRY ALERT: Investors of Sarepta Therapeutics, Inc. that Lost Money are Notified to Contact BFA Law about Ongoing Investigation after Elevidys Death
Jun 18, 2025 03:18PM SRPT NOTIFICATION: Sarepta Therapeutics, Inc. Investors are Notified to Contact BFA Law about Securities Fraud Investigation after Elevidys Death
Jun 18, 2025 06:36AM Sarepta Therapeutics (SRPT) PT Lowered to $40 at Mizuho
Jun 18, 2025 02:07AM TD Cowen Downgrades Sarepta Therapeutics (SRPT) to Hold
Jun 17, 2025 04:02PM Sarepta Therapeutics (SRPT) PT Lowered to $28 at Evercore ISI
Jun 17, 2025 03:18PM SRPT INVESTIGATION: BFA Law Notifies Sarepta Therapeutics, Inc. Investors to Contact the Firm after Second Elevidys Death Triggers Securities Fraud Investigation
View More Recent Stories View Older Stories